UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000035869
Receipt number	R000040850
Scientific Title	Phase I and II trial of combination therapy using nab-Paclitaxel+Pertuzumab+Trastuzumab for HER2 positive metastatic breast cancer
Date of disclosure of the study information	2019/04/01
Last modified on	2019/02/13 19:23:24

---